Our primary objective assessed whether a decline in ankle systolic blood pressure (SBP) to less than 50 mm Hg after treadmill exercise is associated with lower extremity ischemia, as measured by calf muscle hemoglobin oxygen saturation (StO 2 ). Eightyfour patients with peripheral artery disease (PAD) completed a treadmill test. Ankle SBP <50 mm Hg following exercise was observed in only 49% (group 1), whereas 51% had ankle SBP !50 mm Hg (group 2). No group differences were observed for the decline in calf muscle StO 2 to a minimum value (group 1: 18 + 21%, group 2: 20 + 20%; P ¼ .60) and for the time to reach minimum StO 2 (group 1: 224 + 251 seconds, group 2: 284 + 283 seconds; P ¼ .30). Requirement of ankle SBP to decrease below 50 mm Hg after exercise has little clinical significance for assessing ischemia in calf muscle of patients with PAD limited by intermittent claudication.
Introduction
Peripheral artery disease (PAD) is prevalent in 16% of the US population older than 70 years of age and as high as 29% of a high-risk population 1 while the symptom of claudication is prevalent in 5%. 2 Claudication leads to ambulatory dysfunction [3] [4] [5] [6] and a decline in daily physical activities. 7 Patients with PAD have increased risk of cardiovascular events including myocardial infarction, stroke, and death. 8 Diagnosing PAD based on history is difficult as the majority of patients with PAD are asymptomatic. In fact, ''classic'' claudication is the presenting symptoms in as low as 11% of patients with PAD. 1 Ankle-brachial index (ABI) is a highly specific and sensitive noninvasive method for diagnosis of PAD. [9] [10] [11] However, ABI measurement has limitations as ABI accuracy is impaired in elderly patients and in those with diabetes and renal failure due to calcific medial sclerosis. In such settings, other noninvasive measures are helpful to determine the etiology of claudication. Among other tests, measurement of ankle systolic blood pressure (SBP) and ABI following exercise is used to determine the presence and severity of PAD. Although a 20% decline in ABI after exercise is used to evaluate PAD, 12 this does not provide information regarding the magnitude of ischemia in the leg musculature during exercise. An ankle SBP value of 50 mm Hg has been suggested as a cutoff for determining ischemia as etiology of ischemic-induced claudication. 13 However, little evidence is available to validate the cut point that ankle SBP must decline to below 50 mm Hg following exercise to confirm the etiology of ischemic-induced claudication pain.
Near-infrared spectroscopy (NIRS) is a relatively new, noninvasive technique that measures hemoglobin oxygen saturation (StO 2 ) of the calf musculature during exercise [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] and provides real-time assessment of tissue perfusion in calf musculature. A continuous-wave NIRS spectrometer using specific, calibrated wavelengths of near-infrared light quantifies the percentage of StO 2 in the microvasculature of the tissue below the NIRS probe, as well as a small contribution of intracellular myoglobin. The degree of light absorption is dependent on the amount of oxygen attached to hemoglobin in the arterioles, venules, and capillaries. Nonabsorbed light is returned as an optical signal and analyzed to produce a ratio of oxygenated hemoglobin to total hemoglobin, expressed as percentage of StO 2 saturation continuously displayed on the spectrometer interfaced to a laptop computer. Consequently, the NIRS technique is a measure of the balance between local oxygen delivery and oxygen demand and is a valuable technique to obtain vascular measurements from the leg muscle during treadmill exercise.
Calf muscle StO 2 decreases more rapidly during exercise and recovers more slowly in patients with claudication than in controls. 16, 21, 22, 24 Time to the minimum calf muscle StO 2 and the minimum value of StO 2 reflect underlying severity of PAD 17, 25 and have been shown to increase with exercise training. 25 Time to minimum StO 2 has also been shown to highly correlate with peak walking time (PWT), 17 and this correlation is higher than the correlation coefficients obtained between PWT and ABI 17 and between PWT and blood flow at the ankle or calf. 26, 27 Therefore, measurement of continuous StO 2 provides unique information about the microvascular status of exercising calf muscles that is not provided by noninvasive measures, such as ankle SBP and ABI, which are obtained before and after exercise.
In the present study, the primary purpose was to assess whether a decline in ankle SBP to less than 50 mm Hg after treadmill exercise is necessary to determine whether lower extremity ischemia is present, as measured by calf muscle StO 2 . The secondary objective was to estimate the association between calf muscle StO 2 and the absolute and relative percentage changes in ankle SBP and ABI following exercise. We hypothesized that calf muscle StO 2 does not differ significantly between patients with and without a decrease in ankle SBP to an absolute value of 50 mm Hg or less. Second, we hypothesized that declines in macrovascular measures of ankle SBP and ABI obtained after exercise are correlated with the decline in the microvascular measure of calf muscle StO 2 obtained during exercise.
Methods Patients
Recruitment. Patients participated in this study at the General Clinical Research Center (GCRC), at the University of Oklahoma Health Sciences Center (OUHSC). Patients were recruited by referrals from the HSC vascular clinic, as well as by newspaper advertisements for possible enrollment into a randomized controlled exercise rehabilitation study. 28 The procedures used in this study were approved by the Institutional Review Board at the OUHSC. Written informed consent was obtained from each patient prior to investigation.
Screening. Patients with intermittent claudication secondary to vascular insufficiency were included in this study if they met the following criteria: (a) a history of intermittent claudication, (b) ambulation during a graded treadmill test limited by intermittent claudication, 29 and (c) an ABI 0.90 2 or an ABI 0.73 after exercise. 30 Patients were excluded from this study for the following conditions: (a) absence of PAD (ABI >0.90) and ABI >0.73 after exercise, (b) inability to obtain an ABI measure due to noncompressible vessels, (c) asymptomatic PAD, (d) use of medications indicated for the treatment of intermittent claudication (cilostazol and pentoxifylline) within 3 months prior to investigation, (e) exercise tolerance limited by factors other than leg pain (eg, severe coronary artery disease, dyspnea, and poorly controlled blood pressure), ( f) active cancer, kidney failure defined as stage 5 chronic kidney disease (glomerular filtration rate <15 mL/min per 1.73 m 2 ), or abnormal liver function, (g) calf skinfold >50 mm because of potential interference with the light path of the NIRS probe from penetrating the subcutaneous tissue, and (h) pulse arterial oxygen saturation of the index finger <95% because of the potential deleterious effect on calf muscle StO 2 from poor pulmonary gas exchange. A total of 139 patients were evaluated, of which 51 did not have PAD. Of the remaining 88 patients with PAD, 4 patients were deemed ineligible since they did not have limiting claudication and walked the full 20 minutes of treadmill testing, thereby yielding a sample size of 84 patients for the analyses.
Measurements
Medical History, Physical Examination, and Anthropometry. Patients arrived at the GCRC in the morning fasted, but were permitted to take their usual morning medication regimen. To begin the evaluation, demographic information, height, weight, cardiovascular risk factors, comorbid conditions, claudication history, and a list of current medications were obtained from a medical history and physical examination. During the physical examination, arterial oxygen saturation was measured from the index finger using a standard pulse oximeter. Afterward, subcutaneous fat over the medial gastrocnemius muscle was measured from a skinfold obtained by a trained technician using a Lange skinfold caliper according to standard guidelines, 31 and waist and hip circumferences were recorded. 31 Gardner Treadmill Test Claudication times and peak oxygen uptake. Patients performed a progressive, graded treadmill protocol to determine study eligibility and then repeated the test several days later to obtain outcome measures related to peak exercise performance. 29 Both the claudication onset time (COT), defined as the walking time at which the patient first experienced pain, and the PWT, defined as the time at which ambulation could not continue due to maximal pain, were recorded to quantify the severity of claudication. Peak oxygen uptake was measured by oxygen uptake obtained during the peak exercise workload with a Medical Graphics VO2000 metabolic system (Medical Graphics Inc, St Paul, Minnesota). Using these procedures, the test-retest intraclass reliability coefficient is calculated as R ¼ .89 for COT, 29 R ¼ .93 for PWT, 29 and R ¼ .88 for peak oxygen uptake. 32 ABI. After completion of exercise to the point of maximum claudication, 1-minute postexercise ankle SBP was recorded. Both ankle SBP and ABI measures were obtained from the more severely diseased lower extremity before and at 1 minute after the treadmill test and subsequently, every 2 minutes up to 15 minutes. 29, 33 Patients were grouped according to whether their ankle SBP decreased below 50 mm Hg 1 minute following exercise (group 1) or whether their ankle SBP was 50 mm Hg or above (group 2). StO 2 of the calf musculature. Calf muscle StO 2 was measured before, during, and after exercise using a continuous-wave, NIRS spectrometer (InSpectra model 325; Hutchinson Technology, Inc, Hutchinson, Minnesota), an optical cable attached to a 25-mm probe, InSpectra software (version 2.0), and a dedicated laptop computer as previously described. 17 The probe was attached to the skin over the medial gastrocnemius muscle of the more severely affected leg using a double-sided adhesive light-excluding patch. 34 A baseline measure of calf muscle StO 2 was obtained at rest as patients stood on the treadmill for 2 minutes to allow for equilibration. From the start of treadmill exercise, the minimum StO 2 value and the time taken to reach the minimum value were obtained.
Statistical Analyses
A Pearson correlation coefficient, if bivariate normality was a reasonable assumption, or a Spearman rank correlation coefficient, if a bivariate normality assumption was not reasonable, was calculated to quantify the strength of the linear association between pairs of continuous measures. Mean continuous measures were compared between groups defined by ankle SBP values postexercise using an independent sample t test, and proportions were compared between groups using a chisquare test or Fisher exact test for low expected cell counts. All analyses were performed with a 2-tailed significance level of .05.
Results
Eighty-four patients with PAD and limiting claudication were enrolled in the study. Patients were evenly distributed in regard to female sex and non-Caucasian population ( Table 1) . Mean ABI, COT, and PWT were typical for patients with claudication, as were the reductions in ankle SBP, ABI, and calf muscle StO 2 with exercise ( Table 2) .
Of 84 patients, 41 (49%) had ankle SBP <50 mm Hg postexercise after maximum claudication (group 1), whereas the remaining 51% of patients had an ankle SBP value !50 mm Hg (group 2). Time to minimum calf muscle StO 2 was not different between the 2 groups (P ¼ .30) and neither was the minimum value of calf muscle StO 2 (P ¼ .60; Table 3 ). Clinical characteristics also were not different between the 2 groups except baseline ABI, which was lower in group 1 (P < .001).
Calf muscle StO 2 characteristics were compared with other macrovascular measures of PAD (Table 4 ). No significant correlation coefficient was found between the calf muscle StO 2 Abbreviations: ABI, ankle-brachial index; SBP, systolic blood pressure; StO 2 , hemoglobin oxygen saturation; SD, standard deviation. a n ¼ 82. 
Discussion
A main finding of our study was that only 49% of our patients had ankle SBP less than 50 mm Hg postexercise. On comparing the 2 ankle SBP groups, there was no difference in their calf muscle StO 2 characteristics. Time to the minimum StO 2 and the minimum value of calf muscle StO 2 reflect underlying severity of PAD 17, 25 and have been shown to increase with exercise training. 25 Time to minimum StO 2 also has been shown to highly correlate with PWT, 17 and this correlation is higher than the correlation coefficients obtained between PWT and ABI 17 and between PWT and blood flow at the ankle or calf. 26, 27 Calf muscle StO 2 is essentially reflective of the real-time perfusion of the microvasculature of the exercising muscles. The fact that calf muscle StO 2 and ankle SBP did not correlate well is not surprising. Following exercise, a reduction in ankle SBP is due to vascular steal that occurs to maintain microvascular perfusion and oxygen delivery to the muscle. Initially, calf muscle StO 2 values may be maintained relatively well even with a reduction in ankle SBP, particularly in mildly affected patients. Eventually, vascular steal is insufficient to maintain the microvascular circulation and calf muscle StO 2 , particularly in more severe PAD and with more strenuous exercise. There was wide scatter in the data between calf muscle StO 2 measures and ankle SBP. In fact, none of the measures of macrovascular assessment, including absolute ankle SBP, absolute ABI, and the relative declines in ankle SBP and ABI were well correlated with calf StO 2 characteristics. These results suggest that ischemia at tissue level in the exercising calf muscle occurs irrespective of the macrovascular blood supply measured at the ankle.
Pathophysiology of claudication in PAD and its beneficial response to exercise show that anatomic obstruction causing diminished blood flow is not the sole reason for claudication. 35 Ischemia in the exercising calf muscle is thought to be influenced by many other factors rather than just due to impaired macrovascular supply. Oxidative stress, mitochondrial dysfunction, alteration of skeletal muscle metabolism, and endothelial dysfunction are possible factors that influence claudication. 35 Treatment of PAD and implementation of exercise training in PAD show that the pathophysiology of claudication is more complex than a simple mismatch in supply and demand of blood to the calf muscle. Even though exercise training is a well-established treatment of claudication, meta-analysis of exercise studies demonstrated no change in resting ABI. 36 Furthermore, many patients with improvement in ABI after revascularization continue to have poor exercise performance by objective testing. 37 The fact that exercise performance of patients with PAD is improved even with arm ergometry exercise and strength training further strengthens the argument that other factors besides the macrocirculation influence claudication. 38 Although all patients reached a maximum claudication pain end point during exercise, only half of our patients had ankle SBP values less than 50 mm Hg after exercise, whereas the remaining patients had values above 50 mm Hg. This finding indicates that ischemic pain still needs to be considered even at higher postexercise ankle SBP values. Macrovascular measures, such as ankle SBP and ABI, are imprecise measures to assess claudication. Consequently, they should not be used solely without assessment of microvascular function, such as calf muscle StO 2 , when evaluating claudication, particularly in patients with ankle SBP greater than 50 mm Hg. Ischemic claudication should not be ruled out on the basis of postexercise ankle SBP alone.
There are several limitations to this study. The correlation coefficients calculated in this cross-sectional design do not allow causality to be established. Furthermore, the analyses were not adjusted for potential modifying or confounding participant characteristics, although such adjustment is unlikely to change any of the results substantially. For example, in conditions that might increase arterial calcification and ankle SBP measures, such as chronic kidney disease and diabetes, we believe they had minimal influence because patients with severe chronic kidney disease were excluded from the study and because there was no difference in the prevalence of diabetes between groups 1 and 2. Another limitation is that some patients with PAD with arterial calcification may have been excluded because of having an ABI >0.90, but we believe this is unlikely because another exclusion criterion was having an ABI >0.73 after exercise. An exercise-mediated decline in ABI is a hallmark of PAD, with little decline indicative of absence of PAD. Additionally, this study is limited to patients with PAD who have claudication and may not be generalized to patients with less severe (ie, asymptomatic) or more severe (ie, rest pain) PAD. However, the patients in the current study are typical of those with claudication as there was a good proportion of women and African Americans and high prevalence of cardiovascular risk factors for PAD, including smoking, diabetes, hypertension, dyslipidemia, and obesity. Resting ABI and ankle SBP were statistically different between the 2 groups, with group 1 having lower values than group 2. Thus, the findings of the present study appear generalizable to patients with claudication having a wide range in PAD severity and who typically have numerous comorbid conditions.
In summary, none of the ABI or ankle SBP values are significantly correlated with the calf muscle StO 2 values. Furthermore, there is no significant difference in the mean StO 2 measures between the groups of patients defined by ankle SBP <50 mm Hg or ankle SBP !50 mm Hg 1-minute postexercise. Additionally, the confidence intervals for the difference in mean values are wide and therefore, we cannot conclude that the mean measures are equivalent. We conclude that the requirement of an ankle SBP below 50 mm Hg after exercise has little clinical significance for assessing tissue ischemia in the exercising calf muscle of patients with PAD limited by intermittent claudication. There is no association between calf muscle StO 2 and absolute and relative changes in ankle SBP and ABI following exercise. The clinical implication is ischemic-induced claudication needs to be considered in patients even if postexercise ankle SBP is >50 mm Hg. Further studies should be done to examine the microvascular status of exercising muscles. Our study further exemplifies that microvascular ischemia in the exercising calf muscle is not associated with macrovascular ankle SBP measurements.
